Neha Mittal Selected Research

Neha Mittal Research Topics

Disease

9	Neoplasms (Cancer) 09/2023 - 04/2016
6	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 02/2012 - 03/2010
3	Thyroid Neoplasms (Thyroid Cancer) 09/2023 - 03/2022
3	Inflammation (Inflammations) 01/2022 - 01/2009
3	Squamous Cell Carcinoma of Head and Neck 01/2022 - 12/2020
3	Lung Injury 10/2011 - 01/2009
2	COVID-19 06/2023 - 08/2021
2	Mouth Neoplasms (Oral Cancer) 11/2022 - 01/2022
2	Hypoxia (Hypoxemia) 01/2022 - 01/2021
2	Body Weight (Weight, Body) 03/2008 - 01/2008
2	Intestinal Neoplasms (Intestinal Cancer) 03/2008 - 01/2008
1	Gout 03/2024
1	Adenocarcinoma 11/2023
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2023
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2023
1	Thrombocytopenia (Thrombopenia) 10/2023
1	Thyroid Diseases (Thyroid Disease) 10/2023
1	Familial Primary Pulmonary Hypertension 10/2023
1	Melanoma (Melanoma, Malignant) 09/2023
1	Ankylosing Spondylitis 07/2023
1	Sepsis (Septicemia) 01/2023
1	Necrosis 01/2023
1	Infections 01/2023
1	Musculoskeletal Pain 01/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Abscess 01/2023
1	Familial Gigantiform Cementoma 12/2022
1	Medullary Carcinoma 03/2022
1	Exanthema (Rash) 01/2022
1	Leukopenia 01/2022
1	Postherpetic Neuralgia 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Carcinogenesis 01/2022
1	Papillary Thyroid Cancer 05/2020
1	Infertility (Sterility) 01/2019
1	Erythema Nodosum 01/2018
1	Multibacillary Leprosy 01/2018
1	Carcinoma (Carcinomatosis) 10/2016
1	Lung Neoplasms (Lung Cancer) 04/2016
1	Endotoxemia 02/2012

Drug/Important Bio-Agent (IBA)

6	Surface-Active Agents (Surfactants)IBA 02/2012 - 01/2009
4	EndotoxinsIBA 02/2012 - 01/2009
4	LipopolysaccharidesIBA 02/2012 - 01/2009
2	SynaptophysinIBA 09/2023 - 06/2022
2	ChromograninsIBA 09/2023 - 06/2022
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2023 - 03/2008
2	CytokinesIBA 01/2023 - 10/2011
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 05/2011
2	nimotuzumabIBA 01/2022 - 12/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2020
2	EtoricoxibIBA 03/2008 - 01/2008
2	Dimenhydrinate (DMH)FDA LinkGeneric 03/2008 - 01/2008
1	Allopurinol (Remid)FDA LinkGeneric 03/2024
1	MucinsIBA 11/2023
1	CateninsIBA 11/2023
1	Inosine Triphosphate (ITP)IBA 10/2023
1	Minocycline (Cyclops)FDA LinkGeneric 09/2023
1	MART-1 AntigenIBA 09/2023
1	secukinumabIBA 07/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 06/2023
1	GlucocorticoidsIBA 01/2023
1	Liraglutide FDA Link 01/2023
1	Triamcinolone (Aristocort)FDA Link 01/2023
1	CalciumIBA 12/2022
1	SolutionsIBA 11/2022
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 06/2022
1	Tyrosine Kinase InhibitorsIBA 03/2022
1	Keratins (Keratin)IBA 03/2022
1	lenvatinibIBA 03/2022
1	Sorafenib (BAY 43-9006)FDA Link 03/2022
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2022
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	PolyphenolsIBA 01/2022
1	CarcinogensIBA 01/2022
1	Cyclin D1IBA 01/2022
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2022
1	VaccinesIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	baricitinibIBA 01/2022
1	TeaIBA 01/2022
1	remdesivirIBA 01/2022
1	WastewaterIBA 08/2021
1	Thyroglobulin FDA Link 05/2020
1	CalponinsIBA 09/2019
1	Heavy MetalsIBA 01/2019
1	Mucin-1 (CA 15-3 Antigen)IBA 04/2016
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2012
1	Phosphatidylinositols (Phosphatidylinositol)IBA 02/2012

Therapy/Procedure

9	Therapeutics 09/2023 - 05/2011
2	Injections 01/2023 - 01/2008
2	Radiotherapy 01/2021 - 04/2016
1	Immunotherapy 10/2023
1	Intramuscular Injections 01/2023
1	Chemoradiotherapy 01/2022
1	Chemoprevention 01/2022
1	Long-Term Care 08/2021
1	FIM protocol 10/2016